Clinical Research

While our translational researchers work to develop new hope for tomorrow, Mills Breast Cancer Institute also offers patients access to the latest therapies today. We are currently participating in a number of national pharmaceutical and related trials that are open to eligible patients.

Clinical trials have tremendous benefits for patients. Each are assigned a research associate to monitor them through the process. This extra layer of support offers reassurance to patients and ensures the trial investigators administer a very high standard of care. Clinical trials also provide patients the opportunity to obtain treatment they might not otherwise be able to afford.

Examples of current clinical studies include:

Pharmaceutical Trials

• Avastin for locally recurrent/metastic breast cancer
• Femara for first-line therapy in post-menopausal women with metastatic breast cancer relapse following tamoxifin therapy
• Exemestane in postmenopausal women who are at increased risk for developing breast cancer
• Dosing regimens for Capecitabine in combination with intravenous Docetaxel in patients with locally advanced or metastatic breast cancer
• Dosing regimens for Fulvestrant in postmenopausal women with estrogen receptor positive advanced breast cancer progressing or relapsing after previous endocrine therapy
• Safety of Oral Acetyl-L-Carnitine in non-anemic, potentially curable breast cancer patients who are undergoing radiation therapy and experiencing moderate to severe fatigue

For information, please call Carle Cancer Center’s Research and Prevention office at (800) 446-5532.